Clinical Trials

NCT03026062 | COMPLETED | PHASE2
100 participants

Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2017-05-18
Completion:
2025-09-11
Conditions
  • Platinum-Resistant Fallopian Tube Carcinoma
  • Platinum-Resistant Ovarian Carcinoma
  • Platinum-Resistant Primary Peritoneal Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Refractory Fallopian Tube Carcinoma
  • Refractory Ovarian Carcinoma
  • Refractory Primary Peritoneal Carcinoma
Interventions
  • BIOLOGICAL
NCT02392572 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
58 participants

ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2015-11-03
Completion:
2026-11-30
Conditions
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Myelodysplastic Syndrome
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Myelodysplastic Syndrome
Interventions
  • DRUG
No Results Yet
NCT02296684 | COMPLETED | PHASE2
67 participants

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2015-03-25
Completion:
2022-04-05
Conditions
  • Cancer of Head and Neck
  • Head and Neck Cancer
  • Neoplasms, Head and Neck
  • Carcinoma, Squamous Cell of Head and Neck
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma, Head and Neck
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • RADIATION
  • DRUG
NCT02194738 | ACTIVE_NOT_RECRUITING | NA
8300 participants

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2014-09-26
Completion:
2026-09-28
Conditions
  • Stage IB Lung Non-Small Cell Carcinoma AJCC v7
  • Stage II Lung Non-Small Cell Cancer AJCC v7
  • Stage IIA Lung Cancer AJCC v8
  • Stage IIB Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIB Lung Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT01843036 | ACTIVE_NOT_RECRUITING | NA
1650 participants

Durham Connects RCT Evaluation II

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-05
Start Date:
2014-01-31
Completion:
2028-04-30
Conditions
  • Unspecified Child Maltreatment, Suspected
  • Unspecified Child Maltreatment, Confirmed
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page